Immunoassays
News on immunoassay systems and applications.
Alamar Biosciences, Michael J. Fox Foundation Partner on Parkinson's Research
The partners will use Alamar's NULISA proteomics platform to develop assays for identifying biomarkers linked to neuronal synuclein diseases including Parkinson's.
Bio-Techne, Alzpath Partner on Neurodegenerative Disease Research
The companies have developed the Simple Plex Human Phospho-Tau (T217) Alzpath Assay using Bio-Techne's Ella immunoassay instrument.
Quanterix Counting on Multi-Marker Approach as Differentiator in Crowded Alzheimer's Dx Field
Premium
The company expects its five-marker LucentAD Complete test to offer higher performance than single-marker assay and to secure higher reimbursement.
In the wake of suspending guidance to review the business in the first quarter of the year, QuidelOrtho has restructured and resumed offering a financial outlook.
OraSure Technologies Q3 Core Revenues Fall 1 Percent
The firm also announced that it will exit its risk assessment drug testing business going forward.
Oct 18, 2024
Oct 15, 2024
Barclays Upgrades Revvity to Overweight
Sep 17, 2024
Proteomics Firm Nomic Bio Closes $42M Series B Round
Sep 5, 2024
BioMérieux Q2 Revenues Rise 8 Percent
Sep 5, 2024
Craig-Hallum Upgrades QuidelOrtho to Buy
Aug 29, 2024
Aug 8, 2024
Quanterix Q2 Revenues Rise 11 Percent
Jul 30, 2024